Pace Analytical Life Sciences, LLC

Form 483 issued May 4, 2015 · Oakdale, Minnesota

Inspection
Apr 23 – May 4, 2015
Investigator
April L. Young
Observations
1
Pages
2
FEI number
3001452367

In short: On May 4, 2015, FDA issued a Form 483 with 1 observation to Pace Analytical Life Sciences, LLC in Oakdale, Minnesota (FEI 3001452367) after an inspection that ran Apr 23 – May 4, 2015. The investigator was April L. Young. Most observations concern quality system; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

1 of 1 observations on this 483 concern quality system.

Quality system1

Most cited: 21 CFR 211.192 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    There is a failure to thoroughly review any unexplained discrepancy whether or not the batch…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Pace Analytical Life Sciences, LLC?

FDA listed 1 observation on this Form 483, mostly about quality system. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected Pace Analytical Life Sciences, LLC?

April L. Young is named on this Form 483, for the inspection of Apr 23 – May 4, 2015. Each investigator has a profile showing what they cite most.

When was Pace Analytical Life Sciences, LLC inspected by FDA?

The inspection ran Apr 23 – May 4, 2015, and the Form 483 is dated May 4, 2015.

How do I get the full Form 483 for Pace Analytical Life Sciences, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free